Viewing Study NCT00349518

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:33 AM
Ignite Modification Date: 2026-01-24 @ 10:37 PM
Study NCT ID: NCT00349518
Status: WITHDRAWN
Last Update Posted: 2016-02-17
First Post: 2006-07-06
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of Dasatinib in Imatinib Resistant or Intolerant Subjects With Chronic or Advanced Phase CML or Philadelphia Chromosome Positive ALL
Sponsor: Bristol-Myers Squibb
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Myeloid Leukemia View
None Acute Lymphoblastic Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Chronic and Advanced Phase CML and View
None Philadelphia Chromosome Positive ALL with imatinib intolerance or resistance View